Risk factor
Negligible price volatility
Profitability factor
Very strong margins and returns
About
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The...
Company Valuation
Based on key historical and expected multiples, the stock is overvalued relative to its peers. Specifically, the stock is fairly valued on P/E, overvalued on EV/EBITDA, o
Target Price
The average target price of JNJ is 239 and suggests 3% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to decrea
Buy
Sell